A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer

NCT02721641 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche